92 related articles for article (PubMed ID: 25991562)
1. upQMPSF, a Method for the Detection of BRCA1 Exon Copy Number Variants.
Azrak S
Biochem Genet; 2015 Jun; 53(4-6):141-57. PubMed ID: 25991562
[TBL] [Abstract][Full Text] [Related]
2. Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments.
Casilli F; Di Rocco ZC; Gad S; Tournier I; Stoppa-Lyonnet D; Frebourg T; Tosi M
Hum Mutat; 2002 Sep; 20(3):218-26. PubMed ID: 12203994
[TBL] [Abstract][Full Text] [Related]
3. A fluorescent multiplex-DGGE screening test for mutations in the BRCA1 gene.
Kuperstein G; Jack E; Narod SA
Genet Test; 2006; 10(1):1-7. PubMed ID: 16544996
[TBL] [Abstract][Full Text] [Related]
4. Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients.
Armaou S; Konstantopoulou I; Anagnostopoulos T; Razis E; Boukovinas I; Xenidis N; Fountzilas G; Yannoukakos D
Eur J Cancer; 2007 Jan; 43(2):443-53. PubMed ID: 17174087
[TBL] [Abstract][Full Text] [Related]
5. Rapid mutation detection in complex genes by heteroduplex analysis with capillary array electrophoresis.
Velasco E; Infante M; Durán M; Esteban-Cardeñosa E; Lastra E; García-Girón C; Miner C
Electrophoresis; 2005 Jun; 26(13):2539-52. PubMed ID: 15937982
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
Palanca Suela S; Esteban Cardeñosa E; Barragán González E; Oltra Soler S; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Bolufer Gilabert P;
Breast Cancer Res Treat; 2008 Nov; 112(1):63-7. PubMed ID: 18060491
[TBL] [Abstract][Full Text] [Related]
7. Screening for large rearrangements of the BRCA1 gene in German breast or ovarian cancer families using semi-quantitative multiplex PCR method.
Hofmann W; Görgens H; John A; Horn D; Hüttner C; Arnold N; Scherneck S; Schackert HK
Hum Mutat; 2003 Jul; 22(1):103-4. PubMed ID: 12815601
[TBL] [Abstract][Full Text] [Related]
8. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P
Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
[TBL] [Abstract][Full Text] [Related]
9. The 5' region of the MSH2 gene involved in hereditary non-polyposis colorectal cancer contains a high density of recombinogenic sequences.
Charbonnier F; Baert-Desurmont S; Liang P; Di Fiore F; Martin C; Frerot S; Olschwang S; Wang Q; Buisine MP; Gilbert B; Nilbert M; Lindblom A; Frebourg T
Hum Mutat; 2005 Sep; 26(3):255-61. PubMed ID: 16086322
[TBL] [Abstract][Full Text] [Related]
10. A multi-exonic BRCA1 deletion identified in multiple families through single nucleotide polymorphism haplotype pair analysis and gene amplification with widely dispersed primer sets.
Ward BD; Hendrickson BC; Judkins T; Deffenbaugh AM; Leclair B; Ward BE; Scholl T
J Mol Diagn; 2005 Feb; 7(1):139-42. PubMed ID: 15681486
[TBL] [Abstract][Full Text] [Related]
11. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17.
Puget N; Torchard D; Serova-Sinilnikova OM; Lynch HT; Feunteun J; Lenoir GM; Mazoyer S
Cancer Res; 1997 Mar; 57(5):828-31. PubMed ID: 9041180
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia.
Konecny M; Milly M; Zavodna K; Weismanova E; Gregorova J; Mlkva I; Ilencikova D; Kausitz J; Bartosova Z
Breast Cancer Res Treat; 2011 Feb; 126(1):119-30. PubMed ID: 21203900
[TBL] [Abstract][Full Text] [Related]
13. The importance of analysis of long-range rearrangement of BRCA1 and BRCA2 in genetic diagnosis of familial breast cancer.
Kwong A; Chen J; Shin VY; Ho JC; Law FB; Au CH; Chan TL; Ma ES; Ford JM
Cancer Genet; 2015 Sep; 208(9):448-54. PubMed ID: 26271414
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of a 161 kb deletion extending from the NBR1 to the BRCA1 genes in a French breast-ovarian cancer family.
Gad S; Bièche I; Barrois M; Casilli F; Pages-Berhouet S; Dehainault C; Gauthier-Villars M; Bensimon A; Aurias A; Lidereau R; Bressac-de Paillerets B; Tosi M; Mazoyer S; Stoppa-Lyonnet D
Hum Mutat; 2003 Jun; 21(6):654. PubMed ID: 14961556
[TBL] [Abstract][Full Text] [Related]
15. Hereditary nonpolyposis colorectal cancer: pitfalls in deletion screening in MSH2 and MLH1 genes.
Wehner M; Mangold E; Sengteller M; Friedrichs N; Aretz S; Friedl W; Propping P; Pagenstecher C
Eur J Hum Genet; 2005 Aug; 13(8):983-6. PubMed ID: 15870828
[TBL] [Abstract][Full Text] [Related]
16. Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families.
Montagna M; Santacatterina M; Torri A; Menin C; Zullato D; Chieco-Bianchi L; D'Andrea E
Oncogene; 1999 Jul; 18(28):4160-5. PubMed ID: 10435598
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.
Petrij-Bosch A; Peelen T; van Vliet M; van Eijk R; Olmer R; Drüsedau M; Hogervorst FB; Hageman S; Arts PJ; Ligtenberg MJ; Meijers-Heijboer H; Klijn JG; Vasen HF; Cornelisse CJ; van 't Veer LJ; Bakker E; van Ommen GJ; Devilee P
Nat Genet; 1997 Nov; 17(3):341-5. PubMed ID: 9354803
[TBL] [Abstract][Full Text] [Related]
18. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer.
Belogianni I; Apessos A; Mihalatos M; Razi E; Labropoulos S; Petounis A; Gaki V; Keramopoulos A; Pandis N; Kyriacou K; Hadjisavvas A; Kosmidis P; Yannoukakos D; Nasioulas G
BMC Cancer; 2004 Sep; 4():61. PubMed ID: 15353005
[TBL] [Abstract][Full Text] [Related]
20. Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening.
Andersen TI; Eiken HG; Couch F; Kaada G; Skrede M; Johnsen H; Aloysius TA; Tveit KM; Tranebjaerg L; Dørum A; Møller P; Weber BL; Børresen-Dale AL
Hum Mutat; 1998; 11(2):166-74. PubMed ID: 9482581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
